Main Article Content
This study shows the efficacy of Memomet in the treatment of ADHD in children. Total 86 patients were recruited in the study. There were 56 children in the treated group and 30 in placebo treated group. The children were subjected to various test parameters like Yale’s behavioural scale for children with ADHD, Conner’s test and Malin’s test. Both Memomet and Placebo was given at the dose of 1 tsf twice daily for 4 months. At the end of the study period both the groups were evaluated for response to treatment. It was observed that group treated with Memomet responded significantly compared to placebo.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.